127 related articles for article (PubMed ID: 10460810)
1. Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6.
Shin JG; Soukhova N; Flockhart DA
Drug Metab Dispos; 1999 Sep; 27(9):1078-84. PubMed ID: 10460810
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
Ko JW; Sukhova N; Thacker D; Chen P; Flockhart DA
Drug Metab Dispos; 1997 Jul; 25(7):853-62. PubMed ID: 9224780
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate.
Nakajima M; Yoshida R; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 2001 Aug; 29(8):1110-3. PubMed ID: 11454729
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine.
Abdel-Rahman SM; Marcucci K; Boge T; Gotschall RR; Kearns GL; Leeder JS
Drug Metab Dispos; 1999 Jul; 27(7):770-5. PubMed ID: 10383919
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium ozagrel on the activity of rat CYP2D6.
Wu H; Yu W; Huang L; Wang J; Tang X; Yang W; Liu Y; Yu H; Zhu D
Eur J Pharmacol; 2007 Nov; 573(1-3):55-9. PubMed ID: 17651725
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.
Liu KH; Kim MJ; Jeon BH; Shon JH; Cha IJ; Cho KH; Lee SS; Shin JG
J Clin Pharm Ther; 2006 Feb; 31(1):83-91. PubMed ID: 16476124
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine.
Obach RS; Pablo J; Mash DC
Drug Metab Dispos; 1998 Aug; 26(8):764-8. PubMed ID: 9698290
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
Pan LP; Wijnant P; De Vriendt C; Rosseel MT; Belpaire FM
Br J Clin Pharmacol; 1997 Dec; 44(6):557-64. PubMed ID: 9431831
[TBL] [Abstract][Full Text] [Related]
10. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG
Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734
[TBL] [Abstract][Full Text] [Related]
11. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S
Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282
[TBL] [Abstract][Full Text] [Related]
13. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
15. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
Olesen OV; Linnet K
Br J Clin Pharmacol; 2000 Dec; 50(6):563-71. PubMed ID: 11136295
[TBL] [Abstract][Full Text] [Related]
16. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy).
Van LM; Heydari A; Yang J; Hargreaves J; Rowland-Yeo K; Lennard MS; Tucker GT; Rostami-Hodjegan A
J Psychopharmacol; 2006 Nov; 20(6):834-41. PubMed ID: 16478752
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
Robertson P; DeCory HH; Madan A; Parkinson A
Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
[TBL] [Abstract][Full Text] [Related]
18. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
19. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine.
Zhao Y; Hellum BH; Liang A; Nilsen OG
Phytother Res; 2012 Feb; 26(2):277-83. PubMed ID: 21678521
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the time-dependent inactivation of CYP2D6 in cryopreserved human hepatocytes by methylenedioxymethamphetamine (MDMA).
Van LM; Swales J; Hammond C; Wilson C; Hargreaves JA; Rostami-Hodjegan A
Eur J Pharm Sci; 2007 May; 31(1):53-61. PubMed ID: 17387004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]